Ultra-Rare Tumors: Public-Private Partnership Eyed To Boost Drug Development

 
• By Sue Sutter
  
Open notebook
The envisioned public-private partnership would take a transparent, open-notebook approach to drug development for ultra-rare tumors. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet